The Key to Stopping Colon Cancer?
Scientists in Switzerland may have found a way to inhibit the growth of colon cancer in humans, says a new study published in EMBO Molecular Medicine.
Another Company Announces Positive Lupus Drug Data
Immunomedics has become the second biopharmaceutical company in recent weeks to announce a successful trial of its lupus drug.
Protalix Granted Fast-Track Review for Gaucher Drug
The U.S. Food and Drug Administration has granted a fast-track review to Protalix BioTherapeutics’ experimental treatment for Gaucher disease.
NeoPharm Tipped As Stock to Watch
NeoPharm, a biopharmaceutical company developing drugs for cancer treatment, has been tipped as a worthwhile stock on financial website Seeking Alpha.
BioNeutral Ygiene Kills Swine Flu in 20 Seconds, Test Shows
BioNeutral of Newark, NJ, announced that its Ygiene Consumer Grade antimicrobial formulation swiftly eradicated the H1N1 swine flu virus in an independent lab test.
Power3 Medical Files for 3 Patents for Breast Cancer Test
Power3 Medical Products, a company specializing in disease detection through the analysis of proteins, has filed for three patents on its blood test for the early detection of breast cancer.
MediciNova to Buy Avigen for $37 Million
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
SyntheMed REPEL-CV Receives Russian Approval
SyntheMed announced that its REPEL-CV barrier has received approval from the Ministry of Health of the Russian Federation for use in all patients who undergo open heart surgery.
Sirtris Begins Clinical Trials On Anti-Aging Drug
The New York Times reports that at least one company has taken a large step in its quest to extend the human lifespan.
Jennerex Raises $5.1 Million for Oncology Pipeline
Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.